These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6729835)

  • 1. Role of the microsomal FAD-containing monooxygenase in the liver toxicity of thioacetamide S-oxide.
    Chieli E; Malvaldi G
    Toxicology; 1984 May; 31(1):41-52. PubMed ID: 6729835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of thioacetamide hepatotoxicity by phenobarbital pretreatment in rats. Inducibility of FAD monooxygenase system and age effect.
    Zaragoza A; Andrés D; Sarrión D; Cascales M
    Chem Biol Interact; 2000 Jan; 124(2):87-101. PubMed ID: 10670821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of thioacetamide-induced liver necrosis by prior administration of substrates of microsomal flavin-containing monooxygenase.
    De Ferreyra EC; De Fenos OM; Castro JA
    Toxicol Lett; 1983 Aug; 18(1-2):127-31. PubMed ID: 6623535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicokinetics and toxicity of thioacetamide sulfoxide: a metabolite of thioacetamide.
    Chilakapati J; Korrapati MC; Hill RA; Warbritton A; Latendresse JR; Mehendale HM
    Toxicology; 2007 Feb; 230(2-3):105-16. PubMed ID: 17187915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation of thiobenzamide by the FAD-containing and cytochrome P-450-dependent monooxygenases of liver and lung microsomes.
    Tynes RE; Hodgson E
    Biochem Pharmacol; 1983 Nov; 32(22):3419-28. PubMed ID: 6418176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saturation toxicokinetics of thioacetamide: role in initiation of liver injury.
    Chilakapati J; Shankar K; Korrapati MC; Hill RA; Mehendale HM
    Drug Metab Dispos; 2005 Dec; 33(12):1877-85. PubMed ID: 16183780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of thioacetamide on rat liver plasma membrane enzymes and its potentiation by fasting.
    Nikolaev V; Kerimova M; Naydenova E; Dimov S; Savov G; Ivanov E
    Toxicology; 1986 Feb; 38(2):203-8. PubMed ID: 3945971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and toxicity of thioacetamide and thioacetamide S-oxide in rat hepatocytes.
    Hajovsky H; Hu G; Koen Y; Sarma D; Cui W; Moore DS; Staudinger JL; Hanzlik RP
    Chem Res Toxicol; 2012 Sep; 25(9):1955-63. PubMed ID: 22867114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of thioacetamide-induced hepatic necrosis on the regioselective metabolism of S-warfarin by rat liver mixed-function oxidase enzymes.
    Obaseki AO; Jayaraj A; Porter WR
    Biochem Pharmacol; 1983 Aug; 32(16):2385-91. PubMed ID: 6615541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsomal activation of thioacetamide-S-oxide to a metabolite(s) that covalently binds to calf thymus DNA and other polynucleotides.
    Vadi HV; Neal RA
    Chem Biol Interact; 1981 Apr; 35(1):25-38. PubMed ID: 6162577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methimazole-induced modulation of thiobenzamide bioactivation and toxicity.
    Chieli E; Malvaldi G
    Toxicol Lett; 1983 Aug; 18(1-2):147-52. PubMed ID: 6623539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by SKF 525-A of 7-ethoxycoumarin O-deethylation in microsomal and the reconstituted monooxygenase systems from PCB-treated rat livers.
    Kamataki T; Ando M; Ishii K; Kato R
    Jpn J Pharmacol; 1980 Dec; 30(6):841-51. PubMed ID: 6787292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein targets of thioacetamide metabolites in rat hepatocytes.
    Koen YM; Sarma D; Hajovsky H; Galeva NA; Williams TD; Staudinger JL; Hanzlik RP
    Chem Res Toxicol; 2013 Apr; 26(4):564-74. PubMed ID: 23465048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cytochrome P-450 and flavin-containing monooxygenase modifying factors on the in vitro metabolism of amiodarone by rat and rabbit.
    Young RA; Mehendale HM
    Drug Metab Dispos; 1987; 15(4):511-7. PubMed ID: 2888625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of inhibitors of alpha-naphthylisothiocyanate-induced hepatotoxicity on the in vitro metabolism of alpha-naphthylisothiocyanate.
    Traiger GJ; Vyas KP; Hanzlik RP
    Chem Biol Interact; 1985 Jan; 52(3):335-45. PubMed ID: 2982508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the mechanism of metabolism of thioacetamide s-oxide by rat liver microsomes.
    Dyroff MC; Neal RA
    Mol Pharmacol; 1983 Jan; 23(1):219-27. PubMed ID: 6408387
    [No Abstract]   [Full Text] [Related]  

  • 17. Possible role of the acetone-inducible cytochrome P-450IIE1 in the metabolism and hepatotoxicity of thiobenzamide.
    Chieli E; Saviozzi M; Puccini P; Longo V; Gervasi PG
    Arch Toxicol; 1990; 64(2):122-7. PubMed ID: 2350230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of metabolism by flavin-containing monooxygenase in thioacetamide-induced immunosuppression.
    Lee JW; Shin KD; Lee M; Kim EJ; Han SS; Han MY; Ha H; Jeong TC; Koh WS
    Toxicol Lett; 2003 Jan; 136(3):163-72. PubMed ID: 12505269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cobalt protoporphyrin on hepatic drug-metabolizing enzymes. Specificity for cytochrome P-450.
    Spaethe SM; Jollow DJ
    Biochem Pharmacol; 1989 Jun; 38(12):2027-38. PubMed ID: 2742604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covalent modification of lipids and proteins in rat hepatocytes and in vitro by thioacetamide metabolites.
    Sarma D; Hajovsky H; Koen YM; Galeva NA; Williams TD; Staudinger JL; Hanzlik RP
    Chem Res Toxicol; 2012 Sep; 25(9):1868-77. PubMed ID: 22667464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.